Showing 141-150 of 849 results for "".
Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Scurvy Following Gastric Bypass
https://practicaldermatology.com/issues/august-2025/scurvy-following-gastric-bypass/36701/This report highlights a unique case of scurvy presentation following gastric bypass surgery. A 39-year-old female presented for outpatient dermatology follow-up for a rash that had been present for several months, affecting the buttocks, extremities, and trunk.Lashing Out: A New Direction in Lash Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lashing-out-a-new-direction-in-lash-treatment/20743/New eyelash ptosis treatment means no more lash curlers.Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Painless, Non-Invasive Treatment for Non-melanoma Skin Cancer Offers Patients a Convenient Alternative
https://practicaldermatology.com/topics/general-topics/painless-non-invasive-treatment-for-non-melanoma-skin-cancer-offers-patients-a-convenient-alternative/20626/In recent years, an increasing number of clinicians and patients have opted for treatment with an advanced form of radiation called electronic brachytherapy (eBx).Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/Melanoma Vaccine Shows Promise
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-vaccine-shows-promise/23345/Phase 2b data suggest a personalized vaccine may improve disease-free survival.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivCurrents: Cosmetic Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-cosmetic-dermatology/23463/Dumbing Down of Dermatology By Evidence-Based Medicine
https://practicaldermatology.com/topics/practice-management/how-do-you-make-this-do-that/20593/